APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genetic Engineering Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Genetic Engineering Drug Industry Growth and Trends Forecast to 2032

22 December 202594 pages

Choose your research edition.

Industry ResearchGenetic Engineering Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetic Engineering Drug Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Genetic Engineering Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetic Engineering Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetic Engineering Drug Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Genetic Engineering Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Genetic Engineering Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Genetic Engineering Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genetic Engineering Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Genetic Engineering Drug include Tonghua Dongbao Pharmaceutical, Shenzhen Neptunus Interlong Bio-Technique, Shanghai Lansheng Guojian Pharmaceutical, Jiangsu Sihuan Bioengineering, Anhui Anke Biotechnology, GeneScience Pharmaceuticals, Biotech Pharmaceutical, Beijing SL Pharmaceutical and 3SBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Genetic Engineering Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Genetic Engineering Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genetic Engineering Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genetic Engineering Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Genetic Engineering Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Genetic Engineering Drug Market by Company

Tonghua Dongbao Pharmaceutical

Shenzhen Neptunus Interlong Bio-Technique

Shanghai Lansheng Guojian Pharmaceutical

Jiangsu Sihuan Bioengineering

Anhui Anke Biotechnology

GeneScience Pharmaceuticals

Biotech Pharmaceutical

Beijing SL Pharmaceutical

3SBio

Genetic Engineering Drug Segment by Type

Recombinant Human Insulin

Recombinant Human Growth Hormone

Recombinant Human Interferon

Recombinant Human Erythropoietin

Monoclonal Antibody

Genetic Engineering Drug Segment by Application

Medicine

Research

Agriculture

Industrial

Other

Genetic Engineering Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Engineering Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetic Engineering Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Engineering Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Genetic Engineering Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Genetic Engineering Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Recombinant Human Insulin Table 2. Major Company of Recombinant Human Growth Hormone Table 3. Major Company of Recombinant Human Interferon Table 4. Major Company of Recombinant Human Erythropoietin Table 5. Major Company of Monoclonal Antibody Table 6. Global Genetic Engineering Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Genetic Engineering Drug Sales by Type (2021-2026) & (k units) Table 8. Global Genetic Engineering Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Genetic Engineering Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Genetic Engineering Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Genetic Engineering Drug Price by Type (2021-2026) & (US$/unit) Table 12. Global Genetic Engineering Drug Sales by Type (2027-2032) & (k units) Table 13. Global Genetic Engineering Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Genetic Engineering Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Genetic Engineering Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Genetic Engineering Drug Price by Type (2027-2032) & (US$/unit) Table 17. North America Genetic Engineering Drug Sales by Type (2021-2026) & (k units) Table 18. North America Genetic Engineering Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Genetic Engineering Drug Sales by Type (2021-2026) & (k units) Table 20. Europe Genetic Engineering Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Genetic Engineering Drug Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Genetic Engineering Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Genetic Engineering Drug Sales by Type (2021-2026) & (k units) Table 24. Latin America Genetic Engineering Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Genetic Engineering Drug Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Genetic Engineering Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Genetic Engineering Drug Industry Trends Table 28. Genetic Engineering Drug Industry Drivers Table 29. Genetic Engineering Drug Industry Opportunities and Challenges Table 30. Genetic Engineering Drug Industry Restraints Table 31. Global Genetic Engineering Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Genetic Engineering Drug Revenue Market Share by Company (2021-2026) Table 33. Global Genetic Engineering Drug Sales by Company (2021-2026) & (k units) Table 34. Global Genetic Engineering Drug Sales Share by Company (2021-2026) Table 35. Global Genetic Engineering Drug Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Genetic Engineering Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Genetic Engineering Drug Major Company Production Sites and Headquarters Table 38. Global Genetic Engineering Drug Company, Product Type & Application Table 39. Global Genetic Engineering Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Genetic Engineering Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Genetic Engineering Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Genetic Engineering Drug Sales by Region (2021-2026) & (k units) Table 44. Global Genetic Engineering Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Genetic Engineering Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Genetic Engineering Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Genetic Engineering Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Genetic Engineering Drug Sales by Region (2027-2032) & (k units) Table 49. Global Genetic Engineering Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Genetic Engineering Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Genetic Engineering Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Genetic Engineering Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Genetic Engineering Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Genetic Engineering Drug Sales by Application (2021-2026) & (k units) Table 55. Global Genetic Engineering Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Genetic Engineering Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Genetic Engineering Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Genetic Engineering Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Genetic Engineering Drug Sales by Application (2027-2032) & (k units) Table 60. Global Genetic Engineering Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Genetic Engineering Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Genetic Engineering Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Genetic Engineering Drug Price by Application (2027-2032) & (US$/unit) Table 64. North America Genetic Engineering Drug Sales by Application (2021-2026) & (k units) Table 65. North America Genetic Engineering Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Genetic Engineering Drug Sales by Application (2021-2026) & (k units) Table 67. Europe Genetic Engineering Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Genetic Engineering Drug Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Genetic Engineering Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Genetic Engineering Drug Sales by Application (2021-2026) & (k units) Table 71. Latin America Genetic Engineering Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Genetic Engineering Drug Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Genetic Engineering Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Tonghua Dongbao Pharmaceutical Company Information Table 75. Tonghua Dongbao Pharmaceutical Business Overview Table 76. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Portfolio Table 78. Tonghua Dongbao Pharmaceutical Recent Development Table 79. Shenzhen Neptunus Interlong Bio-Technique Company Information Table 80. Shenzhen Neptunus Interlong Bio-Technique Business Overview Table 81. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Portfolio Table 83. Shenzhen Neptunus Interlong Bio-Technique Recent Development Table 84. Shanghai Lansheng Guojian Pharmaceutical Company Information Table 85. Shanghai Lansheng Guojian Pharmaceutical Business Overview Table 86. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Portfolio Table 88. Shanghai Lansheng Guojian Pharmaceutical Recent Development Table 89. Jiangsu Sihuan Bioengineering Company Information Table 90. Jiangsu Sihuan Bioengineering Business Overview Table 91. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Portfolio Table 93. Jiangsu Sihuan Bioengineering Recent Development Table 94. Anhui Anke Biotechnology Company Information Table 95. Anhui Anke Biotechnology Business Overview Table 96. Anhui Anke Biotechnology Genetic Engineering Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Anhui Anke Biotechnology Genetic Engineering Drug Product Portfolio Table 98. Anhui Anke Biotechnology Recent Development Table 99. GeneScience Pharmaceuticals Company Information Table 100. GeneScience Pharmaceuticals Business Overview Table 101. GeneScience Pharmaceuticals Genetic Engineering Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. GeneScience Pharmaceuticals Genetic Engineering Drug Product Portfolio Table 103. GeneScience Pharmaceuticals Recent Development Table 104. Biotech Pharmaceutical Company Information Table 105. Biotech Pharmaceutical Business Overview Table 106. Biotech Pharmaceutical Genetic Engineering Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Biotech Pharmaceutical Genetic Engineering Drug Product Portfolio Table 108. Biotech Pharmaceutical Recent Development Table 109. Beijing SL Pharmaceutical Company Information Table 110. Beijing SL Pharmaceutical Business Overview Table 111. Beijing SL Pharmaceutical Genetic Engineering Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Beijing SL Pharmaceutical Genetic Engineering Drug Product Portfolio Table 113. Beijing SL Pharmaceutical Recent Development Table 114. 3SBio Company Information Table 115. 3SBio Business Overview Table 116. 3SBio Genetic Engineering Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. 3SBio Genetic Engineering Drug Product Portfolio Table 118. 3SBio Recent Development Table 119. North America Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. North America Genetic Engineering Drug Sales by Country (2021-2026) & (k units) Table 121. North America Genetic Engineering Drug Sales Market Share by Country (2021-2026) Table 122. North America Genetic Engineering Drug Sales Forecast by Country (2027-2032) & (k units) Table 123. North America Genetic Engineering Drug Sales Market Share Forecast by Country (2027-2032) Table 124. North America Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Genetic Engineering Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Genetic Engineering Drug Market Share by Country (2021-2026) Table 127. North America Genetic Engineering Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Genetic Engineering Drug Market Share Forecast by Country (2027-2032) Table 129. Europe Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Europe Genetic Engineering Drug Sales by Country (2021-2026) & (k units) Table 131. Europe Genetic Engineering Drug Sales Market Share by Country (2021-2026) Table 132. Europe Genetic Engineering Drug Sales Forecast by Country (2027-2032) & (k units) Table 133. Europe Genetic Engineering Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Genetic Engineering Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Genetic Engineering Drug Market Share by Country (2021-2026) Table 137. Europe Genetic Engineering Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Genetic Engineering Drug Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Genetic Engineering Drug Sales by Country (2021-2026) & (k units) Table 141. Asia-Pacific Genetic Engineering Drug Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Genetic Engineering Drug Sales Forecast by Country (2027-2032) & (k units) Table 143. Asia-Pacific Genetic Engineering Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Genetic Engineering Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Genetic Engineering Drug Market Share by Country (2021-2026) Table 147. Asia-Pacific Genetic Engineering Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Genetic Engineering Drug Market Share Forecast by Country (2027-2032) Table 149. Latin America Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Latin America Genetic Engineering Drug Sales by Country (2021-2026) & (k units) Table 151. Latin America Genetic Engineering Drug Sales Market Share by Country (2021-2026) Table 152. Latin America Genetic Engineering Drug Sales Forecast by Country (2027-2032) & (k units) Table 153. Latin America Genetic Engineering Drug Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Genetic Engineering Drug Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Genetic Engineering Drug Market Share by Country (2021-2026) Table 157. Latin America Genetic Engineering Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Genetic Engineering Drug Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Genetic Engineering Drug Sales by Country (2021-2026) & (k units) Table 161. Middle East and Africa Genetic Engineering Drug Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Genetic Engineering Drug Sales Forecast by Country (2027-2032) & (k units) Table 163. Middle East and Africa Genetic Engineering Drug Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Genetic Engineering Drug Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Genetic Engineering Drug Market Share by Country (2021-2026) Table 167. Middle East and Africa Genetic Engineering Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Genetic Engineering Drug Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Genetic Engineering Drug Distributors List Table 172. Genetic Engineering Drug Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Genetic Engineering Drug Image Figure 2. Global Genetic Engineering Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genetic Engineering Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Genetic Engineering Drug Sales (2021-2032) & (k units) Figure 5. Recombinant Human Insulin Image Figure 6. Global Recombinant Human Insulin Sales YoY Growth (2021-2032) & (k units) Figure 7. Recombinant Human Growth Hormone Image Figure 8. Global Recombinant Human Growth Hormone Sales YoY Growth (2021-2032) & (k units) Figure 9. Recombinant Human Interferon Image Figure 10. Global Recombinant Human Interferon Sales YoY Growth (2021-2032) & (k units) Figure 11. Recombinant Human Erythropoietin Image Figure 12. Global Recombinant Human Erythropoietin Sales YoY Growth (2021-2032) & (k units) Figure 13. Monoclonal Antibody Image Figure 14. Global Monoclonal Antibody Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Genetic Engineering Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Genetic Engineering Drug Market Share by Type 2025 VS 2032 Figure 17. North America Genetic Engineering Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Genetic Engineering Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Genetic Engineering Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Genetic Engineering Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Genetic Engineering Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Genetic Engineering Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Genetic Engineering Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Genetic Engineering Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Genetic Engineering Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Genetic Engineering Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Genetic Engineering Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Medicine Image Figure 30. Global Medicine Sales YoY Growth (2021-2032) & (k units) Figure 31. Research Image Figure 32. Global Research Sales YoY Growth (2021-2032) & (k units) Figure 33. Agriculture Image Figure 34. Global Agriculture Sales YoY Growth (2021-2032) & (k units) Figure 35. Industrial Image Figure 36. Global Industrial Sales YoY Growth (2021-2032) & (k units) Figure 37. Other Image Figure 38. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 39. Global Genetic Engineering Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Genetic Engineering Drug Market Share by Application 2025 VS 2032 Figure 41. North America Genetic Engineering Drug Sales Market Share in Volume by Application in 2025 Figure 42. North America Genetic Engineering Drug Sales Market Share in Value by Application in 2025 Figure 43. Europe Genetic Engineering Drug Sales Market Share in Volume by Application in 2025 Figure 44. Europe Genetic Engineering Drug Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Genetic Engineering Drug Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Genetic Engineering Drug Sales Market Share in Value by Application in 2025 Figure 47. Latin America Genetic Engineering Drug Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Genetic Engineering Drug Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Genetic Engineering Drug Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Genetic Engineering Drug Sales Market Share in Value by Application in 2025 Figure 51. North America Genetic Engineering Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. North America Genetic Engineering Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Genetic Engineering Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Genetic Engineering Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Genetic Engineering Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Europe Genetic Engineering Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Genetic Engineering Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Genetic Engineering Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Genetic Engineering Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Asia-Pacific Genetic Engineering Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Genetic Engineering Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Genetic Engineering Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Genetic Engineering Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Latin America Genetic Engineering Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Genetic Engineering Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Genetic Engineering Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Genetic Engineering Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Middle East and Africa Genetic Engineering Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Genetic Engineering Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Genetic Engineering Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Genetic Engineering Drug Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Genetic Engineering Drug Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Human Insulin
  • Recombinant Human Growth Hormone
  • Recombinant Human Interferon
  • Recombinant Human Erythropoietin
  • Monoclonal Antibody
Applications
  • Medicine
  • Research
  • Agriculture
  • Industrial
  • Other
Companies covered
  • Tonghua Dongbao Pharmaceutical
  • Shenzhen Neptunus Interlong Bio-Technique
  • Shanghai Lansheng Guojian Pharmaceutical
  • Jiangsu Sihuan Bioengineering
  • Anhui Anke Biotechnology
  • GeneScience Pharmaceuticals
  • Biotech Pharmaceutical
  • Beijing SL Pharmaceutical
  • 3SBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Genetic Engineering Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Genetic Engineering Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Genetic Engineering Drug Market by Type
  6. 1.3.1 Recombinant Human Insulin
  7. 1.3.2 Recombinant Human Growth Hormone
  8. 1.3.3 Recombinant Human Interferon
  9. 1.3.4 Recombinant Human Erythropoietin
  10. 1.3.5 Monoclonal Antibody
  11. 1.4 Global Genetic Engineering Drug Market Size by Type
  12. 1.4.1 Global Genetic Engineering Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Genetic Engineering Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Genetic Engineering Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Genetic Engineering Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Genetic Engineering Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Genetic Engineering Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Genetic Engineering Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Genetic Engineering Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Genetic Engineering Drug Industry Trends
  2. 2.2 Genetic Engineering Drug Industry Drivers
  3. 2.3 Genetic Engineering Drug Industry Opportunities and Challenges
  4. 2.4 Genetic Engineering Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Genetic Engineering Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Genetic Engineering Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Genetic Engineering Drug Price (2021-2026)
  4. 3.4 Global Genetic Engineering Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Genetic Engineering Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Genetic Engineering Drug Company, Product Type & Application
  7. 3.7 Global Genetic Engineering Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Genetic Engineering Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Genetic Engineering Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Genetic Engineering Drug Tier 1, Tier 2, and Tier 3
4 Genetic Engineering Drug Regional Status and Outlook
  1. 4.1 Global Genetic Engineering Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Genetic Engineering Drug Historic Market Size by Region
  3. 4.2.1 Global Genetic Engineering Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Genetic Engineering Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Genetic Engineering Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Genetic Engineering Drug Forecasted Market Size by Region
  7. 4.3.1 Global Genetic Engineering Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Genetic Engineering Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Genetic Engineering Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Genetic Engineering Drug by Application
  1. 5.1 Genetic Engineering Drug Market by Application
  2. 5.1.1 Medicine
  3. 5.1.2 Research
  4. 5.1.3 Agriculture
  5. 5.1.4 Industrial
  6. 5.1.5 Other
  7. 5.2 Global Genetic Engineering Drug Market Size by Application
  8. 5.2.1 Global Genetic Engineering Drug Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Genetic Engineering Drug Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Genetic Engineering Drug Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Genetic Engineering Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Genetic Engineering Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Genetic Engineering Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Genetic Engineering Drug Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Genetic Engineering Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Tonghua Dongbao Pharmaceutical
  2. 6.1.1 Tonghua Dongbao Pharmaceutical Company Information
  3. 6.1.2 Tonghua Dongbao Pharmaceutical Business Overview
  4. 6.1.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Portfolio
  6. 6.1.5 Tonghua Dongbao Pharmaceutical Recent Developments
  7. 6.2 Shenzhen Neptunus Interlong Bio-Technique
  8. 6.2.1 Shenzhen Neptunus Interlong Bio-Technique Company Information
  9. 6.2.2 Shenzhen Neptunus Interlong Bio-Technique Business Overview
  10. 6.2.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Portfolio
  12. 6.2.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments
  13. 6.3 Shanghai Lansheng Guojian Pharmaceutical
  14. 6.3.1 Shanghai Lansheng Guojian Pharmaceutical Company Information
  15. 6.3.2 Shanghai Lansheng Guojian Pharmaceutical Business Overview
  16. 6.3.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Portfolio
  18. 6.3.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments
  19. 6.4 Jiangsu Sihuan Bioengineering
  20. 6.4.1 Jiangsu Sihuan Bioengineering Company Information
  21. 6.4.2 Jiangsu Sihuan Bioengineering Business Overview
  22. 6.4.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Portfolio
  24. 6.4.5 Jiangsu Sihuan Bioengineering Recent Developments
  25. 6.5 Anhui Anke Biotechnology
  26. 6.5.1 Anhui Anke Biotechnology Company Information
  27. 6.5.2 Anhui Anke Biotechnology Business Overview
  28. 6.5.3 Anhui Anke Biotechnology Genetic Engineering Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Anhui Anke Biotechnology Genetic Engineering Drug Product Portfolio
  30. 6.5.5 Anhui Anke Biotechnology Recent Developments
  31. 6.6 GeneScience Pharmaceuticals
  32. 6.6.1 GeneScience Pharmaceuticals Company Information
  33. 6.6.2 GeneScience Pharmaceuticals Business Overview
  34. 6.6.3 GeneScience Pharmaceuticals Genetic Engineering Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 GeneScience Pharmaceuticals Genetic Engineering Drug Product Portfolio
  36. 6.6.5 GeneScience Pharmaceuticals Recent Developments
  37. 6.7 Biotech Pharmaceutical
  38. 6.7.1 Biotech Pharmaceutical Company Information
  39. 6.7.2 Biotech Pharmaceutical Business Overview
  40. 6.7.3 Biotech Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Biotech Pharmaceutical Genetic Engineering Drug Product Portfolio
  42. 6.7.5 Biotech Pharmaceutical Recent Developments
  43. 6.8 Beijing SL Pharmaceutical
  44. 6.8.1 Beijing SL Pharmaceutical Company Information
  45. 6.8.2 Beijing SL Pharmaceutical Business Overview
  46. 6.8.3 Beijing SL Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Beijing SL Pharmaceutical Genetic Engineering Drug Product Portfolio
  48. 6.8.5 Beijing SL Pharmaceutical Recent Developments
  49. 6.9 3SBio
  50. 6.9.1 3SBio Company Information
  51. 6.9.2 3SBio Business Overview
  52. 6.9.3 3SBio Genetic Engineering Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 3SBio Genetic Engineering Drug Product Portfolio
  54. 6.9.5 3SBio Recent Developments
7 North America by Country
  1. 7.1 North America Genetic Engineering Drug Sales by Country
  2. 7.1.1 North America Genetic Engineering Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Genetic Engineering Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Genetic Engineering Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Genetic Engineering Drug Market Size by Country
  6. 7.2.1 North America Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Genetic Engineering Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Genetic Engineering Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Genetic Engineering Drug Sales by Country
  2. 8.1.1 Europe Genetic Engineering Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Genetic Engineering Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Genetic Engineering Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Genetic Engineering Drug Market Size by Country
  6. 8.2.1 Europe Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Genetic Engineering Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Genetic Engineering Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Genetic Engineering Drug Sales by Country
  2. 9.1.1 Asia-Pacific Genetic Engineering Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Genetic Engineering Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Genetic Engineering Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Genetic Engineering Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Genetic Engineering Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Genetic Engineering Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Genetic Engineering Drug Sales by Country
  2. 10.1.1 South America Genetic Engineering Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Genetic Engineering Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Genetic Engineering Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Genetic Engineering Drug Market Size by Country
  6. 10.2.1 South America Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Genetic Engineering Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Genetic Engineering Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Genetic Engineering Drug Sales by Country
  2. 11.1.1 Middle East and Africa Genetic Engineering Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Genetic Engineering Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Genetic Engineering Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Genetic Engineering Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Genetic Engineering Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Genetic Engineering Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Genetic Engineering Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Genetic Engineering Drug Value Chain Analysis
  2. 12.1.1 Genetic Engineering Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Genetic Engineering Drug Production Mode & Process
  7. 12.2 Genetic Engineering Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Genetic Engineering Drug Distributors
  10. 12.2.3 Genetic Engineering Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst